AUD/SUD was significant risk factor for HCC in pre-direct-acting antiviral era, and in the post-direct-acting antiviral era among those with active hepatitis C.

AT SABCS 2025, researchers presented surgical outcomes for patients who received 6 months of neoadjuvant endocrine therapy for ER-positive, HER2-negative breast cancer.

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.

Treatment with glucagon-like peptide-1 receptor agonists was associated with lower probabilities of heart, kidney, and lung complications after partial nephrectomy for RCC.

In the HARMONY Alliance Study of European randomized clinical trials, researchers sought to determine if MRD could serve as an intermediate endpoint in intensively treated AML.

Researchers sought to determine whether combination odronextamab plus CHOP would be safe and effective in patients with DLBCL.

The EPCORE FL-1 trial evaluated epcoritamb plus lenalidomide and rituximab versus plus lenalidomide and rituximab for ...

Investigators evaluated the proportion, clinical characteristics, and survival of patients with lung cancer who met or were excluded from USPSTF criteria and used institutional and published data to ...

Gut dysbiosis caused by gastric acid suppression has been shown to affect the efficacy of immune checkpoint inhibitor treatment in some cancers, but not in HCC.

GLP-1 RAs probably have little or no effect on risk for thyroid cancer, pancreatic cancer, breast cancer, or kidney cancer.

Investigators sought to identify a relationship between cruciferous vegetable intake and breast cancer risk in the Nurses’ Health Study (NHS) and NHSII.

Patients with extensive-stage SCLC who received immunochemotherapy before 15:00 hrs exhibited significantly longer PFS, overall survival.